Adnkronos Research and the arrival of new therapies have transformed the management of spinal muscular atrophy (SMA), opening up new perspectives for people living with the disease. Treatment advances, such as the new tablet formulation of risdiplam, now available in Italy, not only restore quality and independence to daily life, but also facilitate continuity of treatment.
These are the themes at the heart of the event 'Brunch & Science: Let's talk about spinal muscular atrophy – The evolution of SMA treatment: when innovation paves the way to independence', organized by Roche Italia in Milan.
https://www.youtube.com/watch?v=i-8jVeDHTD4
Continue on the app
The news of your city, in real time.
Open in app